← Back to Search

Survivorship Care Planning + Telehealth Education for Cancer

N/A

Waitlist Available

Led By Eric Chow

Research Sponsored by Fred Hutchinson Cancer Research Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

History of either adult-onset (age >= 18) lymphoma, breast, colorectal, lung, or prostate cancer

Be older than 18 years old

Must not have

Currently on palliative or hospice care, or considering transferring to such care within the next 3 months

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 8 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial is studying how well self-generated survivorship care plans and telehealth education work in improving knowledge and self-efficacy in cancer survivors living in rural areas.

Who is the study for?

This trial is for adult cancer survivors who finished curative therapy within the last 5 years and have a history of lymphoma, breast, colorectal, lung, or prostate cancer. They must be able to do study tasks like questionnaires and agree to randomization. Participants need access to a phone and can receive materials electronically. It excludes those on palliative care or without telephone access.

What is being tested?

The IMPACT Study tests if self-generated survivorship care plans combined with telehealth education improve knowledge and self-efficacy in rural cancer survivors. The goal is better transition from oncology to primary care and improved communication between healthcare providers.

What are the potential side effects?

Since this trial involves educational interventions rather than medical treatments, traditional side effects are not applicable. However, participants may experience stress or discomfort when discussing their cancer experiences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I had cancer (lymphoma, breast, colorectal, lung, or prostate) as an adult.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am receiving or considering palliative or hospice care soon.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Accuracy of survivors' self-generated survivorship care plans (SCPs) in relation to those based on medical record abstraction

Secondary study objectives

Local oncology clinics' attitudes towards survivorship care implementation

PCP self-efficacy towards survivorship care

Participant perceived self-efficacy: questionnaire using the PROMIS Global 10 and health related self-efficacy scales

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm II (patient-generated SCP, educational counseling)Experimental Treatment3 Interventions

Patients receive a self-generated SCP as in Arm I. Patients also receive a 30-minute telephone-based educational counseling session on survivorship care administered by trained lay health counselors.

Group II: Arm I (patient-generated SCP)Active Control2 Interventions

Patients receive a self-generated SCP (i.e., generated from baseline questionnaire responses).

0 / 2Eligibility criteria met